The battle against cancers in children, adolescents, and young adults i a key focus of the national 2021-2130 Ten-year Strategy for Cancer Control, bolstered by additional annual funding since 2019.
Objectives of the call: To expand and rejuvenate the pool of French research in paediatric oncology, we aim to attract researchers from all nationalities to establish new research teams in France focused on paediatric cancers. This program targets candidates currently conducting research internationnally or who have been in France for no more than 36 months.
Targeted domains: Proposed projects should be innovative, address current challenges in the field, and have potential benefits for patients. They should fall within the scope of fundamental or translational research, excluding purely clinical research, and can span any discipline, including epidemiology and the social sciences and humanities. Projects must align with the technical environment of the host institution and provide significant added value. The projectsz should be designed to span a 60-month period.
Special characteristics: To achieve its goals, the program offers broad eligibility crieteria (no restrictions on age, nationality, professional status, etc.) and particularly attractive financial conditions. The Chair can be combined with other fundings secured by the laureates for the same project.
Registration on the Inserm EVA3 website >>. Only online submission of the application (no paper documents are required): International program-Chair in Paediatric Oncology Research >>
NB: At the beginning of July, our information page will change, and you will be redirected to our new access page of the call for applicaitions.
- Opening of project submission site: July 1st, 2024, 10 AM
- Deadline: September 27, 2024, 5 PM
- Results of the preselected candidates for audition: End of November 2024
- Audition of preselected candidates: December 2024
- Publication of final results: January 2025